Smaller liver grafts could revolutionize transplant safety

NCT ID NCT07247877

ENROLLING_BY_INVITATION Disease control Sponsor: Zhi-Jun Zhu Source: ClinicalTrials.gov โ†—

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at a new way to do liver transplants for people with severe portal hypertension. Instead of using a full-sized liver, doctors will use a smaller piece (small-for-size graft) in an auxiliary transplant, leaving part of the original liver in place. The goal is to see if this method is safer and works as well as the standard transplant. About 396 participants will be followed to compare survival, complications, and whether the high blood pressure in the liver gets better.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
auxiliary liver transplantation using small-for-size grafts
What this could lead to
If successful, this technique could offer a safer alternative to conventional liver transplantation for managing portal hypertension, potentially reducing complications.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. The technique is still being tested and may not be suitable for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.